Novo Nordisk (NYSE: NVO) -- the original Ozempic stock -- jumped higher again Thursday after announcing results from a weight ...

Novo Nordisk › Novo Nordisk's (NYSE: NVO) leading medications have been hot discussion topics for years. Many Americans might ...

Bloomberg journalists discuss today's biggest winners and losers in the stock market. Listen for analysis on the companies ...

Nvov Nordisk stock rose after a study showed Ozempic reduced the risk of heart attack, stroke and death by 23% compared with ...

Novo Nordisk A/S rose the most in a month after its diabetes blockbuster Ozempic beat Eli Lilly & Co.’s older drug Trulicity ...

A senior Novo Nordisk executive on Wednesday described the drugmaker's ongoing trial of its blockbuster obesity medicine for ...

In a new study, Ozempic-maker Novo Nordisk shows that its weight loss pill could achieve the similar efficacy as injectables.

Rybelsus is approved to treat type 2 diabetes but can now officially list its heart benefits as well.

Canadians now have a comprehensive, convenient home delivery option for Ozempic® and Wegovy® prescriptions MISSISSAUGA, ON, ...

Novo Nordisk (NVO) shares rose 6% premarket on Thursday after a real-world study showed its diabetes drug Ozempic ...

Novo Nordisk has a strong financial position and portfolio of weight-loss and diabetes treatments. See why NVO’s stock dip ...

Novo Nordisk Says Ozempic Cuts Risk of Heart Attack, Stroke & Death by 23% Vs. Rival Novo Nordisk's Ozempic reduces the risk ...